C13orf24 Antibody (monoclonal) (M02)
Mouse monoclonal antibody raised against a partial recombinant C13orf24.
|Application ||WB, IHC, IF, E|
|Calculated MW||89805 Da|
|Other Names||Progesterone-induced-blocking factor 1, PIBF1, C13orf24, PIBF|
|Target/Specificity||C13orf24 (NP_006337, 660 a.a. ~ 755 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||C13orf24 Antibody (monoclonal) (M02) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Raychaudhuri S, et al. Nat Genet, 2009 Dec. PMID 19898481.Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. Raghupathy R, et al. J Reprod Immunol, 2009 Jun. PMID 19371956.Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion. Hudi? I, et al. J Perinat Med, 2009. PMID 19290853.The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca. Kozma N, et al. Am J Reprod Immunol, 2006 Feb. PMID 16433831.The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Gerhard DS, et al. Genome Res, 2004 Oct. PMID 15489334.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.